ConductScience.org, home

Paper32420566

Development of mucoadhesive cationic polypeptide micelles for sustained cabozantinib release and inhibition of corneal neovascularization.

Han H and 9 others. J Mater Chem B, 2020. Cited by 45 papers, by iCite.

Cite this record

ConductScience Library. Development of mucoadhesive cationic polypeptide micelles for sustained cabozantinib release and inhibition of corneal neovascularization. Papers, record 32420566. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32420566

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Development of mucoadhesive cationic polypeptide micelles for sustained cabozantinib release and inhibition of corneal neovascularization.
PubMed
Journal
J Mater Chem B
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
45
iCite
Relative citation ratio, by iCite
2.91
iCite
Revised in PubMed
2021-05-19
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Han HHaijie
2Yin QQichuan
3Tang XXiajing
4Yu XXiaoning
5Gao QQiang
6Tang YYelei
7Grzybowski AAndrzej
8Yao KKe
9Ji JJian
10Shentu XXingchao

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdhesivesMajor topic
Angiogenesis InhibitorsMajor topic
AnilidesMajor topic
Biocompatible MaterialsMajor topic
Corneal NeovascularizationMajor topic
PeptidesMajor topic
PyridinesMajor topic
Animals
Cations
Cell Proliferation
Cells, Cultured
Drug Liberation
Humans
Mice
Micelles
Particle Size
Sodium Hydroxide
Surface Properties

Source PubMed

Download CSV of topics

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.

PMIDTitleJournalYearIn PapersSource
41340913From design to Deployment: The innovative role of nanomicelles in targeted ophthalmic therapeutics.Mater Today Bio2025https://conductscience.org/library/papers/41340913PubMed
41121132Transforming corneal alkali burn treatment: unveiling mechanisms and pioneering therapies from bench to bedside.J Transl Med2025https://conductscience.org/library/papers/41121132PubMed
40454890Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape.Small2025https://conductscience.org/library/papers/40454890PubMed
40093887Recent advances and prospects of nanoparticle-based drug delivery for diabetic ocular complications.Theranostics2025https://conductscience.org/library/papers/40093887PubMed
39755928Progress in Nanotechnology for Treating Ocular Surface Chemical Injuries: Reflecting on Advances in Ophthalmology.Adv Sci (Weinh)2025https://conductscience.org/library/papers/39755928PubMed
39367103Novel ophthalmic hyaluronic acid-hydrogel with curcumin nanoparticles for enhanced healing of ulcerative keratitis in rabbit model.Sci Rep2024https://conductscience.org/library/papers/39367103PubMed
39014353Preparation and in vivo and ex vivo studies of sirolimus nano-in-situ gel ophthalmic formulation.J Nanobiotechnology2024https://conductscience.org/library/papers/39014353PubMed
38406994Recent Advances in Nanomedicine for Ocular Fundus Neovascularization Disease Management.Adv Healthc Mater2024https://conductscience.org/library/papers/38406994PubMed
38202631Exploring the Role of Lycium barbarum Polysaccharide in Corneal Injury Repair and Investigating the Relevant Mechanisms through In Vivo and In Vitro Experiments.Molecules2023https://conductscience.org/library/papers/38202631PubMed
37600322Recent development of polymer nanomicelles in the treatment of eye diseases.Front Bioeng Biotechnol2023https://conductscience.org/library/papers/37600322PubMed
37004870Targeted dexamethasone nano-prodrug for corneal neovascularization management.Biomed J2024https://conductscience.org/library/papers/37004870PubMed
36292932Design of Cyclic Peptide-Based Nanospheres and the Delivery of siRNA.Int J Mol Sci2022https://conductscience.org/library/papers/36292932PubMed
36267540An Update on Novel Ocular Nanosystems with Possible Benefits in the Treatment of Corneal Neovascularization.Int J Nanomedicine2022https://conductscience.org/library/papers/36267540PubMed
35600640Ferrostatin-1-loaded liposome for treatment of corneal alkali burn via targeting ferroptosis.Bioeng Transl Med2022https://conductscience.org/library/papers/35600640PubMed
35435328Anti-Oxidative and Anti-Inflammatory Micelles: Break the Dry Eye Vicious Cycle.Adv Sci (Weinh)2022https://conductscience.org/library/papers/35435328PubMed
35261643Emerging pro-drug and nano-drug strategies for gemcitabine-based cancer therapy.Asian J Pharm Sci2022https://conductscience.org/library/papers/35261643PubMed
35185587Tacrolimus Loaded Cationic Liposomes for Dry Eye Treatment.Front Pharmacol2022https://conductscience.org/library/papers/35185587PubMed
34950647Inhibition of Neovascularization and Inflammation in a Mouse Model of Corneal Alkali Burns Using Cationic Liposomal Tacrolimus.Front Bioeng Biotechnol2021https://conductscience.org/library/papers/34950647PubMed
34820575Drug-eluting intraocular lens with sustained bromfenac release for conquering posterior capsular opacification.Bioact Mater2022https://conductscience.org/library/papers/34820575PubMed
34765592Ocular Wnt/β-Catenin Pathway Inhibitor XAV939-Loaded Liposomes for Treating Alkali-Burned Corneal Wound and Neovascularization.Front Bioeng Biotechnol2021https://conductscience.org/library/papers/34765592PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32420566

GET https://conductscience.org/api/papers/v1/32420566/cited_by?page=2